Arterial stiffening: Cause and prevention

Hypertension

Volumn 56, Issue 1, 2010, Pages 29-30

  Cecelja, Marina ^a   Chowienczyk, Philip ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN;

ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ATHEROSCLEROSIS; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DRUG EFFECT; HEART RATE; HUMAN; HYPERTENSION; INFLAMMATION; NONHUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; PULSE PRESSURE; PULSE WAVE;

AGED; AGING; ARTERIES; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; ELASTICITY; HUMANS; MALE; VASCULAR RESISTANCE;

EID: 77953810722     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.154005     Document Type: Note

References (11)

1. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries. Theoretical, Experimental and Clinical Principles. London, United Kingdom: Arnold; 1998.
2. Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Duci-metiere P, Benetos A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001; 37:1236-1241.
3. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002;106:2085-2090.
4. Cecelja M, Chowienczyk P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009;54:1328-1336.
5. Payne RA, Webb DJ. Arterial blood pressure and stiffness in hypertension: is arterial structure important? Hypertension. 2006;48:366-367.
6. McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A, Gallacher J, Ben-Shlomo Y, Cockcroft JR, Wilkinson IB. An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the Caerphilly Prospective Study. Hypertension. 2010;56:36-43.
7. McEniery CM, McDonnell BJ, So A, Aitken S, Bolton CE, Munnery M, Hickson SS, Yasmin, Maki-Petaja KM, Cockcroft JR, Dixon AK, Wilkinson IB. Aortic calcification is associated with aortic stiffness and isolated systolic hypertension in healthy individuals. Hypertension. 2009; 53:524-531.
8. Aikawa E, Nahrendorf M, Figueiredo JL, Swirski FK, Shtatland T, Kohler RH, Jaffer FA, Aikawa M, Weissleder R. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation. 2007;116:2841-2850.
9. Joly L, Djaballah W, Koehl G, Mandry D, Dolivet G, Marie PY, Benetos A. Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification. Eur J Nucl Med Mol Imaging. 2009;36:979-985.
10. Maki-Petaja KM, Hall FC, Booth AD, Wallace SM, Yasmin, Bearcroft PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-a therapy. Circulation. 2006;114:1185-1192.
11. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol. 2001;21: 817-824.